Bonofont® (Bonaphton)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceBromonaphthoquinoneBromonaphthoquinone
Similar drugsTo uncover
  • Bonofont®
    ointment locally externally 
    MUROMSKY INSTRUMENT-MAKING PLANT, OJSC     Russia
  • Bonofont®
    ointment d / eye 
    MUROMSKY INSTRUMENT-MAKING PLANT, OJSC     Russia
    • Dosage form: & nbspointment for topical and topical application
    Composition:
    100 g of ointment contains:
    Active substance: bromonaphthoquinone -0.5 g;
    Excipient: Vaseline - up to 100 g.
    Description:

    Ointment from orange to brownish-orange color.

    Pharmacotherapeutic group:Antiviral for topical use
    ATX: & nbsp

    S.01.A.D   Antiviral drugs

    Pharmacodynamics:

    Antiviral drug, is active against the virus Herpes simplex and some adenoviruses. Suppresses the synthesis of cytoplasmic proteins included in capsids, and disrupts the transport of components of the viral capsid into the cell nucleus, where they are "assembled".

    Pharmacokinetics:

    Data on the pharmacokinetics of the drug are absent.

    Indications:

    Viral diseases of the skin, mucous membranes of the oral cavity and genitalia (herpes simple, surrounding, condyloma acute), herpetic stomatitis and gingivitis.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Pregnancy and lactation.

    Children under 18 years.

    Dosing and Administration:

    Locally, externally.With simple and herpes zoster, the drug is applied to the affected areas of the skin with a thin layer 3-4 times a day (in the genital area - 4-6 applications per day). Treatment is carried out 3 cycles of 5 days with 1-2-day breaks or 2 cycles of 10 days with a 3-5-day break. With diseases of the oral mucosa, the drug is applied to the affected areas with a thin layer 4-6 times a day (treatment course - 3-20 days depending on the severity of the disease).

    To treat genital warts apply the drug 2 times a day for 2 weeks.

    Treatment with ointment is combined with the intake of Bonafton tablets, soluble in the intestine.

    Side effects:

    Allergic reactions. Dermatitis.

    Overdose:

    To date, there have been no cases of drug overdose.

    Interaction:

    Pharmacological interaction with other drugs is not revealed.

    Effect on the ability to drive transp. cf. and fur:

    The drug does not adversely affect the performance of a potentially hazardous activities requiring special attention and quick reactions (driving, etc.).

    Form release / dosage:

    Ointment for topical and topical application 0,5%.

    Packaging:For 15 g or 25 g in tubes are aluminum. Together with the instructions for use are placed in a pack of cardboard.
    Storage conditions:

    At a temperature of no higher than 25 ° C. Keep out of the reach of children.

    Shelf life:

    2 years. Do not use the drug after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:P N001445 / 02
    Date of registration:24.08.2011 / 08.04.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:MUROMSKY INSTRUMENT-MAKING PLANT, OJSC MUROMSKY INSTRUMENT-MAKING PLANT, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp19.02.2017
    Illustrated instructions
      Instructions
      Up